Trade Sino Biopharmaceutical Limited - 1177 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.022305% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.000387% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.28 |
| Open | 3.32 |
| 1-Year Change | -7.78% |
| Day's Range | 3.28 - 3.34 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | 3.30 | 0.04 | 1.23% | 3.26 | 3.34 | 3.26 |
| Nov 14, 2024 | 3.28 | 0.00 | 0.00% | 3.28 | 3.34 | 3.24 |
| Nov 13, 2024 | 3.30 | -0.04 | -1.20% | 3.34 | 3.34 | 3.26 |
| Nov 12, 2024 | 3.34 | 0.02 | 0.60% | 3.32 | 3.42 | 3.30 |
| Nov 11, 2024 | 3.36 | -0.04 | -1.18% | 3.40 | 3.40 | 3.32 |
| Nov 8, 2024 | 3.44 | -0.06 | -1.71% | 3.50 | 3.54 | 3.42 |
| Nov 7, 2024 | 3.48 | 0.06 | 1.75% | 3.42 | 3.50 | 3.40 |
| Nov 6, 2024 | 3.46 | -0.06 | -1.70% | 3.52 | 3.54 | 3.40 |
| Nov 5, 2024 | 3.54 | 0.06 | 1.72% | 3.48 | 3.58 | 3.48 |
| Nov 4, 2024 | 3.52 | -0.06 | -1.68% | 3.58 | 3.64 | 3.48 |
| Nov 1, 2024 | 3.58 | 0.02 | 0.56% | 3.56 | 3.60 | 3.50 |
| Oct 31, 2024 | 3.52 | 0.02 | 0.57% | 3.50 | 3.58 | 3.40 |
| Oct 30, 2024 | 3.48 | 0.00 | 0.00% | 3.48 | 3.56 | 3.44 |
| Oct 29, 2024 | 3.48 | -0.08 | -2.25% | 3.56 | 3.60 | 3.48 |
| Oct 28, 2024 | 3.54 | 0.04 | 1.14% | 3.50 | 3.56 | 3.48 |
| Oct 25, 2024 | 3.52 | 0.02 | 0.57% | 3.50 | 3.54 | 3.50 |
| Oct 24, 2024 | 3.50 | -0.12 | -3.31% | 3.62 | 3.62 | 3.50 |
| Oct 23, 2024 | 3.64 | 0.02 | 0.55% | 3.62 | 3.64 | 3.56 |
| Oct 22, 2024 | 3.62 | -0.02 | -0.55% | 3.64 | 3.70 | 3.60 |
| Oct 21, 2024 | 3.66 | -0.06 | -1.61% | 3.72 | 3.74 | 3.64 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Sino Biopharmeceutical Company profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.| Industry: | Pharmaceuticals (NEC) |
湾仔港湾道1号会展广场辨公大楼41楼09室
HK
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com